Bernstein analyst William Pickering maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report) yesterday and set a price ...

TD Cowen analyst Phil Nadeau maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report) today and set a price target of ...

LONDON, February 28, 2025--Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Android is all about customization, but many devices still have fixed icon sizes. If they can be resized, the option is usually hard to find. Perhaps you want them bigger so you can see them ...

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic ...

2-Year U.S. Treasury Note Continuous Contract $103.457-0.082-0.08% 5-Year U.S. Treasury Note Continuous Contract $107.688-0.117-0.11% 10-Year U.S. Treasury Note Continuous Contract $110.656-0.141 ...

2-Year U.S. Treasury Note Continuous Contract $102.867-0.027-0.03% 5-Year U.S. Treasury Note Continuous Contract $106.523-0.094-0.09% 10-Year U.S. Treasury Note Continuous Contract $109.016-0.219 ...